Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Omni Shoreham Hotel

Dec 05, 2016 1:00 PM - Dec 06, 2016 5:00 PM

2500 Calvert Street NW, , Washington, DC 20008 , USA

Advancing the Science of Study Endpoints

Examine global strategies for selecting study endpoints and the impact of endpoints during the analysis of clinical evidence for various types of drug approval processes.

Closing Summary

Session Chair(s)

Chad  Gwaltney, PhD

Chad Gwaltney, PhD

President

Gwaltney Consulting, United States

Closing Summary

Speaker(s)

René  Allard, PhD

Panelist

René Allard, PhD

CTC, Germany

Contractor

J. Jason  Lundy, PhD

Panelist

J. Jason Lundy, PhD

Outcometrix, United States

Principal

David H. Schubert

Panelist

David H. Schubert

DH Schubert Regulatory Solutions LLC, United States

Ashley F. Slagle, PhD, MS

Panelist

Ashley F. Slagle, PhD, MS

Aspen Consulting, LLC, United States

Principal, Scientific and Regulatory Consulting

Keith  Wenzel

Panelist

Keith Wenzel

DIA Study Endpoints Community, United States

Volunteer

Elektra  Papadopoulos, MD, MPH

Panelist

Elektra Papadopoulos, MD, MPH

AbbVie, United States

Director, Patient Experience Data and Strategy

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.